Recently, the long non-coding RNAs (lncRNAs) family of non-coding RNAs have been identified as one of the main contributors to CC tumorigenesis and could have potential novel diagnostic/prognostic utility in CC [5,8,9,10] As a new intergenic ncRNA, the long intergenic noncoding-regulator of reprogramming; LINC-ROR has been identified as a key player in the development, progression, epithelial to mesenchymal transition (EMT), and invasion/metastasis of multiple cancers, including CC [11,12,13,14,15]. This evidence concerns the gene LINC-ROR and cancer.